Information on drooling
Information on drooling in children with neurodisabilities for patients and parents/carers – developed in collaboration with the Bobath Centre.
Information on drooling in children with neurodisabilities for patients and parents/carers – developed in collaboration with the Bobath Centre.
Guidance for patients and parents/carers on how to administer Sialanar® orally
Guidance for patients and parents/carers on how to administer Sialanar® via feeding tubes
Guidance for patients and parents/carers on how to administer Sialanar® orally
Guidance for patients and parents/carers on how to administer Sialanar® via feeding tubes
The mTDS can be shared with parents/carers to complete to assess drooling and inform consultations.
The DIS can be shared with parents/carers to complete in order to assess drooling over a period of time, this may be a useful tool to evaluate an intervention or medication.
Case study summary of a patient ‘Tim’ who was prescribed Sialanar®
Guidance on dose conversion providing equivalent doses of Sialanar® and 1mg/5ml glycopyrronium bromide oral solutions (intended for UK HCPs only)
Proveca run educational sessions on a regular basis covering a variety of topics, register here to be the first to know what’s coming up or head to our resources section to catch up on previous sessions.
UK-SIA-24-0038 | June 2024
Please see below for information on how to report an adverse event in the UK or Republic of Ireland:
UK
Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Proveca Limited. Phone: 0333 200 1866 E-Mail: medinfo@proveca.com
Republic of Ireland
Adverse events should be reported. Reporting forms and information can be found at: www.hpra.ie.
Adverse events should also be reported to Proveca Limited. Phone: +44 333 200 1866 E-Mail: medinfo@proveca.com